Impact of Rotavirus Vaccination in Australian Children Below 5 Years of Age: A Database Study
This article, published in Human Vaccines & Immunotherapeutics, reports on a study that compared rotavirus hospitalization rates in children less than five years of age before and after the introduction of the rotavirus vaccine Rotarix® in three Australian territories and observed substantial reductions ranging from 45 to 87 percent. Considerable reductions in all-cause gastroenteritis were also observed not only among children who received the vaccine but also among children in New South Wales and the Australian Capital Territory who were too old to have received the vaccine, indicating probable indirect protection resulting from infant vaccination.
Author: Pendleton A, Galic M, Clarke C, et al.
» Visit web page (English)
(Located at www.landesbioscience.com)
Citation: Pendleton A, Galic M, Clarke C, et al. Impact of Rotavirus Vaccination in Australian Children Below 5 Years of Age: A Database Study. Human Vaccines & Immunotherapeutics. 2013;9(8):1617-1625.
Resource types: Peer-reviewed journal